Achilles Therapeutics PLC
(STU:698)
€
0.79
0 (0%)
Market Cap: 33.73 Mil
Enterprise Value: -67.27 Mil
PE Ratio: 0
PB Ratio: 0.28
GF Score: 36/100 Achilles Therapeutics PLC (STU:698) Transcripts
- Achilles Therapeutics PLC at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) TranscriptApr 24, 2023
- Achilles Therapeutics PLC at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Achilles Therapeutics PLC at Eqt Life Sciences BioCapital Europe TranscriptMar 09, 2023
- Achilles Therapeutics PLC at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Achilles Therapeutics PLC ESMO IO Webcast Call TranscriptDec 06, 2022
- Achilles Therapeutics PLC at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Achilles Therapeutics PLC to Highlight TRACERx Study Presentations from the 2022 AACR Annual Meeting - Fireside Chat TranscriptApr 14, 2022
- Achilles Therapeutics PLC at Needham Healthcare Conference (Virtual) TranscriptApr 12, 2022
- Achilles Therapeutics PLC SITC and Corporate Update Call TranscriptNov 12, 2021
- 1